Filing Details

Accession Number:
0001127602-16-053152
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-05-23 17:56:16
Reporting Period:
2016-05-23
Filing Date:
2016-05-23
Accepted Time:
2016-05-23 17:56:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1062822 Lexicon Pharmaceuticals Inc. LXRX Pharmaceutical Preparations (2834) 760474169
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1434095 F James Tessmer 8800 Technology Forest Place
The Woodlands TX 77381
Vp, Finance & Accounting No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-05-23 6,000 $6.23 21,946 No 4 M Direct
Common Stock Disposition 2016-05-23 6,000 $13.00 15,946 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2016-05-23 6,000 $0.00 6,000 $6.23
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
18,899 2025-02-05 No 4 M Direct
Footnotes
  1. Effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Tessmer on May 16, 2016.
  2. Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant (2/5/16) and vests 1/48th per month for each month of service thereafter.